bexarotene has been researched along with Lymphomatoid Papulosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dreyer, S; Goh, C; Smart, C | 1 |
| Zic, JA | 1 |
| Aiba, S; Fujimura, T; Furudate, S; Hidaka, T; Kambayashi, Y; Sato, Y; Tanita, K | 1 |
| Duvic, M; Krathen, RA; Ward, S | 1 |
1 review(s) available for bexarotene and Lymphomatoid Papulosis
| Article | Year |
|---|---|
Diagnosis and Management of Cutaneous Lymphomas Including Cutaneous T-cell Lymphoma.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Antineoplastic Agents, Immunological; Arthropods; Bexarotene; Bites and Stings; Brentuximab Vedotin; Diagnosis, Differential; Humans; Hyperlipidemias; Hypothyroidism; Lymphoma, Primary Cutaneous Anaplastic Large Cell; Lymphoma, T-Cell, Cutaneous; Lymphomatoid Papulosis; Mycosis Fungoides; Peripheral Nervous System Diseases; Prognosis; Sezary Syndrome; Skin Diseases; Skin Neoplasms | 2021 |
1 trial(s) available for bexarotene and Lymphomatoid Papulosis
| Article | Year |
|---|---|
Bexarotene is a new treatment option for lymphomatoid papulosis.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Anticarcinogenic Agents; Bexarotene; Female; Humans; Lymphomatoid Papulosis; Male; Middle Aged; Palliative Care; Prospective Studies; Tetrahydronaphthalenes | 2003 |
2 other study(ies) available for bexarotene and Lymphomatoid Papulosis
| Article | Year |
|---|---|
Lichen planopilaris in a patient treated with bexarotene for lymphomatoid papulosis.
Topics: Bexarotene; Hodgkin Disease; Humans; Lichen Planus; Lymphomatoid Papulosis; Skin Neoplasms | 2020 |
Successful control of phototherapy-resistant lymphomatoid papulosis with oral bexarotene.
Topics: Antineoplastic Agents; Bexarotene; Female; Humans; Lymphomatoid Papulosis; Middle Aged; Phototherapy; Skin; Skin Neoplasms; Treatment Outcome | 2018 |